XENE
$36.50+1.53%
Xenon Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.2% of IWMNasdaq Composite · 0.01% of ONEQRussell 3000 · 0.008% of IWV
Xenon Pharmaceuticals Inc. total returns by year (including dividends)
As of market close, Oct 22, 2026
Xenon Pharmaceuticals Inc. total returns by year (2015–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $44.82 | $36.50 | 0.0% | -18.6% | |
| 2025 | $39.20 | $44.82 | 0.0% | +14.3% | |
| 2024 | $46.06 | $39.20 | 0.0% | -14.9% | |
| 2023 | $39.43 | $46.06 | 0.0% | +16.8% | |
| 2022 | $31.24 | $39.43 | 0.0% | +26.2% | |
| 2021 | $15.38 | $31.24 | 0.0% | +103.1% | |
| 2020 | $13.11 | $15.38 | 0.0% | +17.3% | |
| 2019 | $6.31 | $13.11 | 0.0% | +107.8% | |
| 2018 | $2.83 | $6.31 | 0.0% | +123.4% | |
| 2017 | $7.70 | $2.83 | 0.0% | -63.3% | |
| 2016 | $8.04 | $7.70 | 0.0% | -4.2% | |
| 2015 | $19.75 | $8.04 | 0.0% | -59.3% |
- Annualized
- +8.9%
- 2015–2026
- Average year
- +24.3%
- 11 full years
- Best year
- +123.4%
- 2018
- Worst year
- -63.3%
- 2017
- Positive years
- 7/11
- 64% up
Annualized (CAGR)
+8.9%
2015–2026
Average year
+24.3%
11 full years
Best year
+123.4%
2018
Worst year
-63.3%
2017
Positive years
7/11
64% up
Total return by period#
Annual
-100%-50%0%50%100%
2015-59%'15
2016-4.2%'16
2017-63%'17
2018+123%'18
2019+108%'19
2020+17%'20
2021+103%'21
2022+26%'22
2023+17%'23
2024-15%'24
2025+14%'25
2026-19%'26
Methodology#
Total returns, dividends reinvested, measured on XENE. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Xenon Pharmaceuticals Inc.'s average annual return?
- Since 2015, Xenon Pharmaceuticals Inc. (XENE) has returned about 8.9% a year (the compound annual growth rate) and an average calendar-year return of 24.3%.
- What were Xenon Pharmaceuticals Inc.'s best and worst years?
- Over 2015–2026, the best year was 2018 (+123.4%) and the worst was 2017 (-63.3%).
- How often is Xenon Pharmaceuticals Inc. up in a year?
- 7 of the 11 full years since 2015 were positive — about 64% of the time.
More on Xenon Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100